BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18502088)

  • 1. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions.
    Mathew J; Asgeirsson KS; Cheung KL; Chan S; Dahda A; Robertson JF
    Eur J Surg Oncol; 2009 Feb; 35(2):113-22. PubMed ID: 18502088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy in breast cancer.
    Charfare H; Limongelli S; Purushotham AD
    Br J Surg; 2005 Jan; 92(1):14-23. PubMed ID: 15635596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future roles of neoadjuvant chemotherapy in operable breast cancer.
    Kim R; Osaki A; Toge T
    Clin Breast Cancer; 2005 Aug; 6(3):223-32; discussion 233-4. PubMed ID: 16137432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary chemotherapy in breast cancer.
    Smith IE; al-Moundhri M
    Biomed Pharmacother; 1998; 52(3):116-21. PubMed ID: 9755804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant induction chemotherapy.
    Schwartz G
    Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative (neoadjuvant) systemic treatment of breast cancer.
    Kaufmann M; von Minckwitz G; Rody A
    Breast; 2005 Dec; 14(6):576-81. PubMed ID: 16199160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary systemic therapy of breast cancer.
    Sachelarie I; Grossbard ML; Chadha M; Feldman S; Ghesani M; Blum RH
    Oncologist; 2006 Jun; 11(6):574-89. PubMed ID: 16794237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary chemotherapy or hormonotherapy for patients with breast cancer.
    Brain EG; Misset JL; Rouëss J
    Cancer Treat Rev; 1999 Aug; 25(4):187-97. PubMed ID: 10448127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive markers of response to neoadjuvant chemotherapy in breast cancer.
    Tewari M; Krishnamurthy A; Shukla HS
    Surg Oncol; 2008 Dec; 17(4):301-11. PubMed ID: 18467090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for locally advanced breast cancer.
    Specht J; Gralow JR
    Semin Radiat Oncol; 2009 Oct; 19(4):222-8. PubMed ID: 19732686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for operable breast cancer.
    Mieog JS; van der Hage JA; van de Velde CJ
    Br J Surg; 2007 Oct; 94(10):1189-200. PubMed ID: 17701939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future prospects of neoadjuvant chemotherapy in treatment of primary breast cancer.
    Wang HC; Lo SS
    Semin Surg Oncol; 1996; 12(1):59-66. PubMed ID: 8821411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
    Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
    Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast cancer].
    Kobayashi T; Yamazaki H; Nakamura T; Ogihara A; Fujii T; Hirano A; Uno S; Yoshida K; Nagata T; Uchida K; Kubo H; Tozaki M; Kanehira C; Miyazawa Y; Suzuki M; Kuraishi Y
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1814-25. PubMed ID: 11729473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of radiation therapy on the use of primary ("neoadjuvant") systemic treatment of breast cancer].
    Souchon R; Dunst J; Hartmann KA
    Strahlenther Onkol; 2006 Apr; 182(4):202-9. PubMed ID: 16622621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy treatment of breast cancer--a review.
    Buzdar AU
    Cancer; 2007 Dec; 110(11):2394-407. PubMed ID: 17941030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
    Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
    Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.